Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 397

1.

A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection.

Spera JM, Ugalde JE, Mucci J, Comerci DJ, Ugalde RA.

Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16514-9. Epub 2006 Oct 19.

2.

Brucella alters the immune response in a prpA-dependent manner.

Spera JM, Comerci DJ, Ugalde JE.

Microb Pathog. 2014 Feb-Mar;67-68:8-13. doi: 10.1016/j.micpath.2014.01.003. Epub 2014 Feb 4.

3.

A Brucella virulence factor targets macrophages to trigger B-cell proliferation.

Spera JM, Herrmann CK, Roset MS, Comerci DJ, Ugalde JE.

J Biol Chem. 2013 Jul 12;288(28):20208-16. doi: 10.1074/jbc.M113.453282. Epub 2013 May 29.

4.

Identification of Brucella abortus virulence proteins that modulate the host immune response.

Wang Y, Chen Z, Qiu Y, Ke Y, Xu J, Yuan X, Li X, Fu S, Cui M, Xie Y, Du X, Wang Z, Huang L.

Bioengineered. 2012 Sep-Oct;3(5):303-5. doi: 10.4161/bioe.21005. Epub 2012 Jun 29.

5.

Interleukin-10 downregulates protective immunity to Brucella abortus.

Fernandes DM, Baldwin CL.

Infect Immun. 1995 Mar;63(3):1130-3.

6.
8.

Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells.

Briones G, Iñón de Iannino N, Roset M, Vigliocco A, Paulo PS, Ugalde RA.

Infect Immun. 2001 Jul;69(7):4528-35.

9.

The role of a Brucella abortus lipoprotein in intracellular replication and pathogenicity in experimentally infected mice.

Kim DH, Son BG, Lim JJ, Lee JJ, Kim DG, Lee HJ, Min W, Rhee MH, Kim KD, Chang HH, Kim S.

Microb Pathog. 2013 Jan;54:34-9. doi: 10.1016/j.micpath.2012.09.002. Epub 2012 Sep 21.

PMID:
23006628
10.

A bile salt hydrolase of Brucella abortus contributes to the establishment of a successful infection through the oral route in mice.

Delpino MV, Marchesini MI, Estein SM, Comerci DJ, Cassataro J, Fossati CA, Baldi PC.

Infect Immun. 2007 Jan;75(1):299-305. Epub 2006 Nov 6.

11.

Inflammatory response of TLR4 deficient spleen macrophages (CRL 2471) to Brucella abortus S19 and an isogenic ΔmglA deletion mutant.

Jacob J, Makou P, Finke A, Mielke M.

Int J Med Microbiol. 2016 May;306(3):141-51. doi: 10.1016/j.ijmm.2016.02.006. Epub 2016 Feb 20.

PMID:
26946956
12.

Characterization of Brucella abortus sigma factor sigma54 (rpoN): genetic complementation of Sinorhizobium meliloti ntrA mutant.

Iannino F, Ugalde RA, Iñón de Iannino N.

Microb Pathog. 2008 Nov-Dec;45(5-6):394-402. doi: 10.1016/j.micpath.2008.09.002. Epub 2008 Sep 27.

PMID:
18926896
13.

The siderophore 2,3-dihydroxybenzoic acid is not required for virulence of Brucella abortus in BALB/c mice.

Bellaire BH, Elzer PH, Baldwin CL, Roop RM 2nd.

Infect Immun. 1999 May;67(5):2615-8.

14.

Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.

Grilló MJ, Manterola L, de Miguel MJ, Muñoz PM, Blasco JM, Moriyón I, López-Goñi I.

Vaccine. 2006 Apr 5;24(15):2910-6. Epub 2006 Jan 6.

PMID:
16439039
15.
16.

Brucella abortus INTA2, a novel strain 19 (Delta)bp26::luc (Delta)bmp18 double mutant lacking drug resistance markers.

Campos E, Cravero SL, Delgui L, Mora I, Kahn N, Arese AI, Rossetti OL.

Vet Microbiol. 2002 Jun 5;87(1):1-13.

PMID:
12079742
18.

Contradictory roles for antibody and complement in the interaction of Brucella abortus with its host.

Hoffmann EM, Houle JJ.

Crit Rev Microbiol. 1995;21(3):153-63. Review.

PMID:
8845060
19.

Inactivation of the type IV secretion system reduces the Th1 polarization of the immune response to Brucella abortus infection.

Rolán HG, Tsolis RM.

Infect Immun. 2008 Jul;76(7):3207-13. doi: 10.1128/IAI.00203-08. Epub 2008 May 5.

20.

Supplemental Content

Support Center